Literature DB >> 21955632

Limbal and conjunctival epithelium after corneal cross-linking using riboflavin and UVA.

Gregor Wollensak1, Cosimo Mazzotta, Thomas Kalinski, Saadettin Sel.   

Abstract

PURPOSE: To assess possible cellular damage in the corneal and conjunctival epithelium after corneal cross-linking treatment.
METHODS: Riboflavin-dextran solution was applied every 5 minutes to the right eyes of 3 rabbits 10 minutes before and 30 minutes during the irradiation with UVA light of 370 nm and an irradiance of 3 mW/cm at the 8- to 10-o'clock position, including conjunctival, limbal, and central corneal epithelium. In addition, 3 rabbits were treated with UVA light only. The rabbits were killed 24 hours later. The treated eyes were examined histologically using hematoxylin-eosin and periodic acid-Schiff staining, immunohistochemistry, and a terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick-end labeling (TUNEL) apoptosis assay and compared with the left fellow eyes, which served as controls.
RESULTS: There was no epithelial defect on fluorescein staining. No apoptosis was found in the corneal limbal epithelium, keratocytes, or endothelial cells in the irradiated area. In the adjacent conjunctival epithelium, rare superficial conjunctival epithelial cells were positive in TUNEL staining in all animals. Anti-multicytokeratin-positive staining was demonstrated in both the limbal corneal and the conjunctival epithelium. The proliferation marker Ki-67 was identified in the basal cell layer of the limbal epithelium. The frequency and distribution pattern of goblet cells, multicytokeratin, and the proliferation marker Ki-67 were the same in all eyes compared with the untreated fellow control eyes.
CONCLUSIONS: Standard corneal cross-linking does not induce significant cellular epithelial damage as assessed by histological methods. Further studies on possible genotoxic and long-term changes would be helpful to complete the risk assessment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955632     DOI: 10.1097/ICO.0b013e3182199d7e

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

Review 1.  [Complications of corneal cross-linking].

Authors:  T G Seiler; G Schmidinger; I Fischinger; T Koller; T Seiler
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

2.  Collagen crosslinking in the management of leaking cystic blebs: a prospective study.

Authors:  Bonnie Nga Kwan Choy; Ming Ming Zhu; Jennifer Wei Huen Shum; Wing Lau Ho; Jonathan Cheuk Hung Chan; Alex Lap Ki Ng; Jimmy Shiu Ming Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-21       Impact factor: 3.117

3.  Pharmacologic alternatives to riboflavin photochemical corneal cross-linking: a comparison study of cell toxicity thresholds.

Authors:  MiJung Kim; Anna Takaoka; Quan V Hoang; Stephen L Trokel; David C Paik
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-10       Impact factor: 4.799

4.  [Riboflavin UVA cross-linking for keratoconus].

Authors:  P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

5.  Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human corneal endothelial cells.

Authors:  Jiong Wang; Tanja Stachon; Timo Eppig; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-22       Impact factor: 3.117

Review 6.  Potential Effects of Corneal Cross-Linking upon the Limbus.

Authors:  Johnny E Moore; Davide Schiroli; C B Tara Moore
Journal:  Biomed Res Int       Date:  2016-09-05       Impact factor: 3.411

7.  Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis.

Authors:  Sabine Kling; Arthur Hammer; Alain Conti; Farhad Hafezi
Journal:  Transl Vis Sci Technol       Date:  2017-01-30       Impact factor: 3.283

8.  Protection of Corneal Limbus from Riboflavin Prevents Epithelial Stem Cell Loss after Collagen Cross-Linking.

Authors:  Hyo Kyung Lee; Jin Suk Ryu; Hyun Jeong Jeong; Mee Kum Kim; Joo Youn Oh
Journal:  J Ophthalmol       Date:  2018-06-03       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.